Boni E. Elewski - Concepedia

Author

Boni E. Elewski

University of Alabama at Birmingham ORCID

Also Known As

Alma Cruz Santana, B E Elewski, B Elewski, B. E. Elewski, B. Elewski, B.E. ELEWSKI, B.E. Elewski, BONI E. ELEWSKI, Bom E Elewski, Boni E Elewski

456

Publications

17.8K

Citations

H-Index

108

Concepts

All Affiliations

University of Alabama at Birmingham University Hospitals of Cleveland Case Western Reserve University Icahn School of Medicine at Mount Sinai Probity Medical Research

About

Boni E. Elewski is an author at University of Alabama at Birmingham specializing in dermatology, medicine, and dermatopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	87	5.6K
2	Allergy	4	4	72
3	Public Health	2	2	295
4	Social Sciences	2	2	53
5	Health Sciences	1	1	37

Boni E. Elewski

160

Publications

12.2K

Citations

H-Index

Page 1

	Year	Citations
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials Richard G. Langley, Boni E. Elewski, Mark Lebwohl, New England Journal of Medicine	2014	1.9K
The prevalence of acne in adults 20 years and older Christin N. Collier, Julie Harper, Wendy C. Cantrell, Journal of the American Academy of Dermatology Adults 20EpidemiologyDermatologyClinical Dermatology	2007	552
A large-scale North American study of fungal isolates from nails: The frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns Mahmoud A. Ghannoum, Rana Hajjeh, Richard Scher, Journal of the American Academy of Dermatology Fungal IsolatesFungal DiversityAntifungal Susceptibility PatternsFungal DistributionPlant Pathology	2000	527
Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies Alan Menter, Joel M. Gelfand, Cody Connor, Journal of the American Academy of Dermatology Systemic Nonbiologic TherapiesSystemic TreatmentClinical DermatologyDermatologyScleroderma	2020	314
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials Kim Papp, Alan Menter, Mai Abe, British Journal of Dermatology	2015	310
Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Journal of the American Academy of Dermatology RheumatologyMedicinePsoriasis Severity MeasuresClinical DermatologyJoint Aad–npf Guidelines	2020	307
Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial* Jonathan I. Silverberg, D. Toth, Thomas Bieber, British Journal of Dermatology	2020	304
Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002 K. Wade Foster, Mahmoud A. Ghannoum, Boni E. Elewski Journal of the American Academy of Dermatology Cutaneous Fungal InfectionFungal PathogenAntifungal AgentsMedicineClinical Epidemiology	2004	276
Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial Craig A. Elmets, Jaye L. Viner, Alice P. Pentland, JNCI Journal of the National Cancer Institute	2010	240
Prevalence of Onychomycosis in Patients Attending a Dermatology Clinic in Northeastern Ohio for Other Conditions Boni E. Elewski Archives of Dermatology Diagnostic MycologyMedicineClinical DermatologyDermatology ClinicClinical Mycology	1997	233

Page 1